Combination Antibiotic-Steroid for Ocular Inflammation Filed for FDA Approval

ISTA Pharmaceuticals Inc., which develops eye-care treatments said Thursday it filed a new drug application with the U.S. Food and Drug Administration for its combination antibiotic steroid to fight ocular inflammation.

The topical product, called T-Pred, is a combination of tobramycin and prednisolone acetate.

The company finished a Phase III clinical trial of the treatment candidate during the fourth quarter of 2005. ISTA expects to launch the drug in mid-2007 if it is approved.

Link []


Leave a Reply

Protected by Comment Guard Pro